3 Profitable Companies That May Still Be Risky Investments
A recent analysis by StockStory highlights that profitability alone isn't a guarantee of sound investment, identifying three companies—Transcat, Lincoln Electric, and Forestar Group—that, despite being profitable, present significant risks to investors. These risks stem from issues such as declining operating margins, eroding returns on capital, lagging revenue growth, and negative free cash flow. The report recommends careful consideration of operational challenges and market dynamics alongside profitability when evaluating investments.
Gear up for Transcat (TRNS) Q4 earnings: Wall Street estimates for key metrics
This article provides Wall Street estimates for Transcat's (TRNS) Q4 earnings, focusing on key financial metrics like revenue, earnings per share, and segment performance. Analysts anticipate increased revenue and adjusted earnings per share, driven by growth in both the Service and Distribution segments. The report also highlights the company's historical performance, stock price changes, and recent analyst rating changes.
Wall Street's Mixed Signals: One Buy, Two Sells in May 2026 Analysis
A recent StockStory analysis reveals Wall Street's divided opinions on three stocks, with a buy recommendation for Skyward Specialty Insurance (SKWD) and sell signals for Transcat (TRNS) and Purple (PRPL). While analysts generally project significant upside, sell ratings are rare due to potential conflicts of interest. The report outlines specific financial concerns for TRNS and PRPL, contrasting them with SKWD's strong performance indicators.
COO pay package at Transcat (NASDAQ: TRNS) set for fiscal 2027
Transcat, Inc. (NASDAQ: TRNS) has announced an increase in compensation for its Chief Operating Officer, Michael W. West, effective March 29, 2026, for the fiscal year ending March 27, 2027. Mr. West's new compensation package includes a base salary of $425,000, a target performance-based cash incentive of 40% of his base salary, and a target long-term equity incentive of 65% of his base salary. These changes were approved by the Compensation Committee of Transcat's Board of Directors on May 13, 2026.
3 Profitable Stocks We Steer Clear Of
This article from StockStory identifies three profitable companies—Transcat (TRNS), Lincoln Electric (LECO), and Forestar Group (FOR)—that investors should avoid due to concerns like declining margins, eroding returns on capital, and unexciting growth trends. Despite their profitability, the analysis suggests these companies face challenges that limit their future potential, advocating for better investment opportunities elsewhere. The article also promotes StockStory's platform for identifying high-quality stocks and momentum picks.
Press Release: Transcat to Host Fourth Quarter Fiscal Year 2026 Conference Call and Webcast on Tuesday, May 26, 2026 at 4:30 P.m. Eastern Time
Transcat (NASDAQ: TRNS) will host a conference call and webcast on Tuesday, May 26, 2026, at 4:30 PM ET to discuss its financial results for the fourth quarter and fiscal year 2026. The company will issue its earnings release for the period after the market close on the same day. Interested parties can access the webcast or dial into the call for a Q&A session.
Transcat to Host Fourth Quarter Fiscal Year 2026 Conference Call and Webcast on Tuesday, May 26, 2026 at 4:30 p.m. Eastern Time
Transcat, Inc. (Nasdaq: TRNS) announced it will host a conference call and webcast on Tuesday, May 26, 2026, at 4:30 p.m. ET to discuss its financial results for the fourth quarter of fiscal year 2026, which ended March 28, 2026. President and CEO Jaime Irick and CFO Thomas Barbato will lead the call, reviewing results, corporate strategy, and outlook, followed by a Q&A session. A telephonic replay and webcast archive will be available after the live event.
Transcat Inc stock (US89376R1095): earnings momentum and calibration demand in focus
Transcat Inc recently reported strong fiscal 2025 third-quarter results, showing increased revenue and earnings driven by robust demand for its calibration services and product sales. The company specializes in providing calibration and laboratory services alongside distributing test and measurement instruments, playing a critical role in regulated industries like pharmaceuticals and aerospace. Transcat's business model relies on recurring revenue from services and strategic acquisitions, positioning it as a key player in ensuring compliance and accuracy in industrial and life science sectors for US investors.
How Transcat Inc. (TRNS) Affects Rotational Strategy Timing
This article analyzes Transcat Inc. (TRNS) using AI models, identifying a neutral sentiment in shorter horizons that could alleviate a long-term weak bias. It details an exceptional 57.0:1 risk-reward short setup and outlines three trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels for different risk profiles. The analysis includes multi-timeframe signal data, highlighting support and resistance levels.
Transcat (TRNS) Gained from Underlying Demand And Customer Activity
Conestoga Capital Advisors highlighted Transcat, Inc. (NASDAQ: TRNS) as a leading contributor in its first-quarter 2026 investor letter, citing its improved underlying demand, customer activity, and return to 7% service organic revenue growth. The company, which provides calibration and testing services to highly regulated industries, showed steady execution and recurring revenue characteristics crucial for its performance. Despite a challenging quarter for the Russell Microcap Growth Index, Transcat's exposure to resilient markets like life sciences and aerospace was seen as encouraging.
Transcat, Inc. (NASDAQ:TRNS) Receives Consensus Recommendation of "Hold" from Analysts
Transcat, Inc. (NASDAQ:TRNS) has received a "Hold" consensus recommendation from analysts, with an average 12-month target price of $105.33. The company reported mixed quarterly results, missing EPS estimates but exceeding revenue forecasts. Institutional investors show high ownership and have increased their stakes in the company.
Transcat, Inc. $TRNS Shares Sold by Conestoga Capital Advisors LLC
Conestoga Capital Advisors LLC reduced its stake in Transcat, Inc. by 3.2% in the fourth quarter, now owning 10.11% of the company valued at approximately $53.5 million. Other institutional investors like Vanguard Group Inc. and Bamco Inc. NY increased their holdings. Analyst sentiment is mixed, with a "strong sell" from Zacks but a consensus "Hold" rating and a target price of $105.33 from five analysts.
Vanguard holds 5.09% of Transcat (NASDAQ: TRNS) — 475,732 shares
Vanguard Capital Management reported a beneficial ownership of 475,732 shares, or 5.09%, of Transcat Inc (NASDAQ: TRNS) common stock as of March 31, 2026, as disclosed in a Schedule 13G filing. Vanguard exercises sole dispositive power over all these shares and sole voting power over 68,571 shares. This significant passive stake indicates that Vanguard views Transcat as an investment rather than an attempt to influence control, with holdings managed across various Vanguard funds and accounts.
Teachers Retirement System of The State of Kentucky Invests $1.97 Million in Transcat, Inc. $TRNS
The Teachers Retirement System of The State of Kentucky recently acquired a new position in Transcat, Inc., valued at approximately $1.97 million, representing about 0.37% of the company's stock. Other institutional investors like Vanguard Group Inc., Bamco Inc. NY, Ameriprise Financial Inc., ArrowMark Colorado Holdings LLC, and Bank of America Corp DE have also modified their holdings, with institutional investors collectively owning 98.34% of Transcat's stock. Despite a recent analyst downgrade to "strong sell," the company maintains a "Hold" consensus rating with a target price of $105.33, and its stock performance shows a 52-week range between $50.23 and $97.08.
HC Wainwright & Co. reiterated coverage on Transcat with a new price target
HC Wainwright & Co. has reiterated its coverage on Transcat (TRNS), setting a new price target. This information comes from Quantisnow, a platform providing real-time market data and news for retail investors, aggregating various financial insights. The article also lists recent analyst ratings and related news for Transcat, including acquisitions and insider filings.
HC Wainwright & Co. reiterated coverage on Transcat with a new price target
HC Wainwright & Co. has reiterated its coverage on Transcat Inc. (TRNS) and provided a new price target. The article, sourced from Quantisnow, highlights that this insight is part of real-time market data the platform offers to retail investors, covering analyst ratings, SEC filings, and other financial news. Transcat Inc. is an industrials company with recent analyst ratings and insider transaction activities also noted.
Press Release: Transcat Announces Fourth Quarter Fiscal Year 2025 Conference Call and Webcast
Transcat, Inc. announced it will host a conference call and webcast on Tuesday, May 21, 2024, to discuss its financial results for the fourth quarter and fiscal year ended March 30, 2024. The results will be released after the market closes on Monday, May 20, 2024. Management will provide an overview of the company's performance, followed by a Q&A session.
Transcat acquires Costa Rica-based SCM for $13 million, enters Latin America
Transcat (NASDAQ:TRNS) has announced the acquisition of SCM, a Costa Rica-based calibration, repair, and validation service provider, for $13 million. This strategic move establishes Transcat's presence in Latin America and is expected to be immediately accretive to earnings. SCM, which generated approximately $4 million in revenue in 2023, will continue to be managed by its current leadership team.
Royce & Associates Reports 6.58% Stake in Transcat | TRNS SEC Filing - Form SCHEDULE 13G
Royce & Associates has filed a Schedule 13G, disclosing a 6.58% stake in Transcat (TRNS). This stake amounts to 614,253 shares of common stock as of March 31, 2026, over which Royce & Associates holds sole voting and dispositive power. The filing indicates a passive investment purpose and notes that Royce & Associates disclaims any pecuniary interest in the securities.
Transcat Inc stock (US89376R1095): Why does its calibration niche matter more now for U.S. investors
Transcat Inc. (US89376R1095) is highlighted as a strategic investment for its critical calibration and compliance services, which are essential for industries prioritizing measurement accuracy and quality control. The company's dual revenue model, combining service with product sales, and its expansion strategy through acquisitions make it a resilient play in a demanding market. Regulatory tightening and industrial automation are key drivers for Transcat's continuous growth, offering a stable investment opportunity for U.S. investors.
Transcat Inc stock (US89376R1095): Why does its calibration niche matter more now for U.S. investors
Transcat Inc (US89376R1095) is highlighted as a compelling investment due to its specialized calibration and compliance services, which are critical for industries like pharmaceuticals and aerospace. The company's business model combines service revenue with product sales, offering diversified income streams and stability. With increasing regulatory pressures and demand for precision across industries, Transcat's niche focus is becoming more vital for investors seeking resilient growth.
Transcat Expands Global Footprint with Acquisition of Costa Rica-Based SCM Metrology
Transcat, Inc. has acquired SCM Metrology and Laboratories S.A. for approximately $13 million, establishing its first operational presence in Latin America. This acquisition strengthens Transcat's support for multinational customers in regulated markets and expands its calibration services and distribution sales in Central America. SCM Metrology is an ECA-accredited calibration laboratory with strong partnerships with medical device and life sciences manufacturers, which aligns strategically with Transcat's existing customer base.
Transcat expands into Latin America with $13M acquisition
Transcat Inc. has acquired SCM Metrology and Laboratories S.A., a calibration services provider in Costa Rica, for approximately $13 million cash. This acquisition marks Transcat's first operational presence in Latin America, strengthening its support for multinational customers and expanding its services into high-growth, highly regulated markets. SCM Metrology serves medical device and life sciences companies in Costa Rica's Coyol Free Trade Zone.
Analysts Offer Insights on Industrial Goods Companies: Transcat (TRNS) and Ralliant Corporation (RAL)
Two analysts have issued bullish ratings for industrial goods companies Transcat (TRNS) and Ralliant Corporation (RAL). Lake Street analyst Max Michaelis maintained a Buy rating on Transcat with a $105.00 price target, while Morgan Stanley analyst Christopher Snyder maintained a Buy rating on Ralliant Corporation, setting a target of $45.00. Both companies received positive analyst consensus ratings.
Transcat, Inc. (NASDAQ:TRNS) Given Consensus Rating of "Hold" by Analysts
Five research firms have issued a consensus "Hold" rating for Transcat, Inc. (NASDAQ:TRNS), with an average 1-year price target of $105.3333. Despite some analysts cutting their ratings, institutional investment in Transcat has increased significantly over recent quarters. The company reported quarterly earnings below consensus but exceeded revenue expectations, with analysts predicting $2.3 EPS for the current fiscal year.
Transcat Outperforms Electro-Sensors in Financial Analysis
A financial analysis determined Transcat (NASDAQ:TRNS) is a more favorable investment than Electro-Sensors (NASDAQ:ELSE). Transcat demonstrates higher revenue and earnings, greater institutional ownership, and better analyst ratings, alongside outperforming in 13 out of 15 key financial metrics. Its share price is also less volatile than the S&P 500, making it a more attractive option for investors in the small-cap technology sector.
Transcat acquires Costa Rica calibration firm for $13 million By Investing.com
Transcat Inc. (NASDAQ:TRNS) has acquired SCM Metrology and Laboratories S.A., a Costa Rica-based calibration services provider, for approximately $13 million in cash. This acquisition marks Transcat's first operational presence in Latin America, expanding its services into a new market. SCM Metrology, with over 20 years of operation, serves more than 550 clients, including multinational medical device and life sciences companies, offering calibration services, equipment sales, and consulting.
Transcat Acquires SCM Metrology to Expand into Latin America
Transcat, Inc. has acquired SCM Metrology and Laboratories S.A., a Costa Rican company, to expand its calibration and measurement services into the Latin American market. This acquisition provides Transcat with a strategic foothold in an opportunity-rich region and aligns with Transcat's core business through SCM's existing customer base and operations. The move is expected to enhance Transcat's geographic reach and service offerings.
Transcat acquires Costa Rica-based SCM for $13 million, enters Latin America
Transcat has acquired Costa Rica-based SCM, a calibration, repair, inspection, and validation services provider, for $13 million. This strategic acquisition marks Transcat's entry into the Latin American market, enhancing its global metrology services presence. SCM is expected to generate approximately $3.5 million in revenue during its first full year under Transcat.
Transcat, Inc. acquired SCM Metrology and Laboratories S.A. for CRC 13 million on April 9, 2026.
Transcat, Inc. has announced the acquisition of SCM Metrology and Laboratories S.A. for CRC 13 million. The acquisition was completed on April 9, 2026, with Transcat paying a cash consideration subject to customary adjustments and holdback provisions.
$13M deal gives Transcat its first operational base in Latin America
Transcat, Inc. (Nasdaq: TRNS) has acquired SCM Metrology and Laboratories S.A. for approximately $13 million in cash, marking its first operational expansion into Latin America. This acquisition enhances Transcat's ability to serve multinational customers in highly regulated markets, particularly in medical device and life sciences, by providing a broader local service footprint and creating new distribution sales opportunities in Costa Rica. SCM brings over 20 years of experience and is an ISO/IEC 17025-accredited calibration laboratory, strengthening Transcat's global service capabilities.
Ophir Asset Management Pty Ltd Acquires Significant Stake in Transcat Inc
Ophir Asset Management Pty Ltd has acquired 482,038 shares of Transcat Inc (TRNS) at $70.21 per share, making it 3.66% of Ophir's total holdings and a 5.20% position in Transcat. Transcat Inc, a provider of calibration and laboratory services, is noted as modestly undervalued with strong growth potential, as evidenced by its 12.44% stock gain since the transaction and robust profitability metrics. This strategic move by Ophir reflects confidence in Transcat's market position and future growth prospects.
Transcat Stock Rises After Analyst Upgrade
Shares of Transcat, Inc. rose after Zacks Research upgraded the stock from 'strong sell' to 'hold', with the price climbing above its 50-day moving average. This upgrade signals a more neutral outlook despite the company recently missing its quarterly earnings estimates. Investors will be monitoring future earnings and analyst ratings to assess the company's ongoing performance.
Transcat (NASDAQ:TRNS) Stock Rating Lowered by Zacks Research
Zacks Research downgraded Transcat (NASDAQ:TRNS) from "hold" to "strong sell," aligning with Weiss Ratings' "sell" rating, though the consensus analyst rating remains "Hold" with a $105.33 price target. The company recently missed EPS expectations but exceeded revenue estimates, with its stock trading around $75.52. Institutional ownership in Transcat is significantly high at 98.34%.
JPMorgan Chase & Co. Acquires 22,164 Shares of Transcat, Inc. $TRNS
JPMorgan Chase & Co. significantly increased its stake in Transcat, Inc. by 259.1% during the third quarter, acquiring an additional 22,164 shares, bringing its total to 30,719 shares valued at $2.249 million. Other major institutions like Vanguard and Bank of America also increased their positions, with institutional investors now collectively owning 98.34% of Transcat. Despite missing EPS estimates last quarter, analysts have an average rating of "Moderate Buy" for Transcat with a target price of $105.33.
SG Americas Securities LLC Grows Stock Holdings in Transcat, Inc. $TRNS
SG Americas Securities LLC significantly increased its stake in Transcat, Inc. by 112.6% in the fourth quarter, bringing its total holdings to 27,732 shares valued at approximately $1.57 million. This move is part of a broader trend of institutional investors raising their positions, with hedge funds and other large investors now owning 98.34% of the stock. Analysts have a "Moderate Buy" rating for Transcat with an average price target of $105.33, despite the company recently missing EPS estimates but exceeding revenue forecasts.
Transcat Stock Crosses Key Technical Milestone
Shares of Transcat, Inc. (NASDAQ:TRNS), a scientific instrument calibration company, rose above their 50-day moving average on Monday, April 7, 2026, reaching $76.50. This technical milestone is often considered a bullish signal for potential stock upside, despite past analyst skepticism. Investors will closely monitor if the stock maintains this momentum.
Transcat (NASDAQ:TRNS) Shares Cross Above Fifty Day Moving Average - What's Next?
Transcat (NASDAQ:TRNS) shares have moved above their 50-day moving average, signaling short-term bullish momentum. Despite missing quarterly EPS estimates, the company exceeded revenue expectations, and institutional ownership remains high. Analysts currently assign a "Moderate Buy" rating with a target price of $105.33, though opinions are varied.
Transcat, Inc. Forms Golden Cross, Signaling Potential Bullish Breakout Ahead
Transcat, Inc. has recently formed a Golden Cross, a technical indicator suggesting a potential bullish market shift. The stock has outperformed the S&P 500 in daily and weekly performance, alongside significant year-to-date growth of 31.34%. Despite a mixed long-term performance, these recent indicators could signal a turnaround in investor sentiment for the microcap company.
High-Valuation Stocks Analysis: Risks for Transcat, SolarEdge vs. Woodward's Strength - News and Statistics
This article analyzes high-valuation stocks, highlighting risks for Transcat and SolarEdge while pointing to Woodward's strength. Transcat is noted for its high forward P/E, rising costs, and declining operating margins. SolarEdge faces significant market challenges, declining sales, and cash burn. In contrast, Woodward is presented as a strong performer with increasing market share, exceptional revenue growth, and improved operating margins.
Transcat Stock Review 2026: Performance, Margins & Valuation Outlook - News and Statistics
Transcat stock has shown strong price performance, gaining 5.3% since October 2025 despite a declining S&P 500. However, an analysis from Yahoo Finance raises concerns about the company's profitability, citing a 2.8 percentage point decrease in operating margin over five years and a 6.8% annual decline in earnings per share over the last two years. The valuation is also flagged, with the stock trading at a forward price-to-earnings multiple of 37.5, suggesting limited upside potential relative to risk.
Transcat (TRNS) CEO Jaime Irick listed as director and officer in Form 3
Transcat Inc. CEO Jaime A. Irick has filed an initial insider ownership report (Form 3), identifying him as both a director and the President and CEO of the company. The filing indicates no insider transactions or derivative positions, serving primarily to establish his initial beneficial ownership of company securities. This report acts as an opening inventory sheet for his holdings, with no reported buying or selling activity.
Transcat : Initial Statement of Beneficial Ownership (Form 3)
Transcat, Inc. filed an Initial Statement of Beneficial Ownership (Form 3) with the SEC for Jaime A. Irick, who was appointed President and CEO, effective March 29, 2026. The filing indicates that Irick does not beneficially own any derivative or non-derivative securities at the time of this initial statement. The document was published by Transcat Inc. on April 2, 2026, via Public Technologies.
Ophir (NASDAQ: TRNS) holds 5.2% — 482,038 shares in Transcat
Ophir Asset Management Pty Ltd has reported a beneficial ownership of 482,038 shares, representing a 5.2% stake in Transcat Inc. (NASDAQ: TRNS). This ownership is split between two funds: Ophir Global Opportunities Fund and Ophir High Conviction Fund, with 201,933 and 280,105 shares, respectively. The filing, a SCHEDULE 13G, indicates passive investment intent, granting Ophir sole voting and dispositive power over these shares.
Transcat Inc Stock: Calibration Services Leader with Steady Growth in Precision Measurement Markets
Transcat Inc (NASDAQ: TRNS) is a leading provider of calibration and compliance services for industries requiring precision measurement accuracy in North America. The company's dual service and distribution model, stable leadership, and focus on regulated sectors like life sciences and aerospace position it for steady growth. Investors consider Transcat appealing for its defensive qualities, low volatility, and recurring revenue streams, despite potential risks from client concentration and economic slowdowns.
[Form 4] TRANSCAT INC Insider Trading Activity
TRANSCAT INC's Sr. VP Finance & CFO, Thomas L. Barbato, engaged in routine equity compensation activity, including the conversion of Restricted Stock Units (RSUs) into common stock and subsequent tax withholdings. After these transactions, Barbato directly held 3,690 shares of Transcat common stock, along with various outstanding RSU grants and stock options. The filing details the specific transactions, share amounts, and prices, indicating a neutral impact on the company.
Vanguard amendment lists 0 shares of Transcat Inc (TRNS) after realignment
The Vanguard Group has filed an amended SCHEDULE 13G/A form, reporting 0 shares of Transcat Inc (TRNS) common stock, which represents 0% beneficial ownership of the class. This change results from an internal realignment within Vanguard, leading certain subsidiaries to report their holdings separately as per SEC Release No. 34-39538. The filing is administrative and does not indicate any share purchases or sales, but rather a reallocation of reporting responsibilities.
Transcat, Inc. $TRNS Shares Sold by Riverbridge Partners LLC
Riverbridge Partners LLC reduced its stake in Transcat, Inc. by 17.1% in Q4, selling 69,708 shares but retaining a significant holding valued at $19.15 million. This comes as Transcat reported mixed Q4 earnings, missing EPS estimates but exceeding revenue forecasts. The company currently holds a "Moderate Buy" rating from analysts with a consensus price target of $105.33, despite a recent Zacks downgrade from "strong sell" to "hold."
Winners And Losers Of Q4: Transcat (NASDAQ:TRNS) Vs The Rest Of The Maintenance and Repair Distributors Stocks
This article analyzes the Q4 performance of several maintenance and repair distributors, highlighting Transcat (TRNS) as a top performer with strong revenue growth despite missing EBITDA and EPS estimates. It also covers VSE Corporation (VSEC) as the best Q4 performer despite a stock drop, and Distribution Solutions (DSGR) as the weakest. The report notes that while revenues generally beat estimates, the sector as a whole has seen a decline in share prices.
Winners And Losers Of Q4: Transcat (NASDAQ:TRNS) Vs The Rest Of The Maintenance and Repair Distributors Stocks
This article analyzes the Q4 performance of maintenance and repair distributors, highlighting Transcat (TRNS) as a top performer with significant revenue growth. It also identifies VSE Corporation (VSEC) for its strong financial quarter despite a stock decline, and Distribution Solutions (DSGR) as the weakest performer against analyst estimates. The piece concludes with a market update noting a shift from AI/crypto concerns to geopolitical risks impacting oil supply and inflation.
